A recent study indicates that individuals who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who end traditional lifestyle plans.
Published data in a prominent health publication demonstrates that while obese individuals can lose substantial amounts of their body weight while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals buying these treatments should be cognizant of the risk of rapid rebound weight gain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb.
This pace of regain implies a reversion to starting weight within about a year and a half.
Weighing Therapies
The study, which reviewed dozens of studies involving over 9,000 of participants, compared the effects of these new drugs with older methods.
Scientists note that individuals who shed pounds through lifestyle changes alone usually see a slower creep back—around 100 grams monthly—after stopping.
Understanding the Quick Rebound
Doctors believe the mechanism of the jabs is key to understanding the heightened regain.
The injections mimic a body's own chemical called GLP-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the body to produce less of its endogenous hormone, and could reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this hormone supplement means appetite is uncontrolled, making overeating far more likely."
A Lifelong Disease?
Health authorities recommend the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Professionals say that, given the likelihood of weight regain, the treatment should be considered long-term.
This perspective is reinforced by drug manufacturers, who state that the results "highlight the chronic nature of excess weight," comparing it to managing conditions like hypertension.
Patient Testimonies
Users who have stopped the medication report a intense resurgence of hunger.
"I experienced a switch that goes on and I was suddenly extremely hungry," said one woman.
The struggle is compounded if patients have not established lasting lifestyle or habit changes during treatment.
Growing Interest
Figures suggest that millions of people in the UK have tried these injections in the last 12 months, with interest being substantial.
- Adoption is higher among females compared to males.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Finally, experts stress that while these medications are potent agents for shedding pounds, they are not a permanent fix and maintained weight loss hinges on integrated lifestyle support.
